46
Participants
Start Date
November 3, 2022
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
nivolumab combined with SOX
nivolumab + SOX (3 cycles) before surgery → radical surgery (D2) → nivolumab + SOX (3 cycles) after surgery → nivolumab monotherapy maintenance (11 cycles);
RECRUITING
Zhejiang Cancer Hospital, Hangzhou
Xiangdong Cheng
OTHER